Physician profile
Brian Thomas Sleasman
NPI 1215386628
$14,426.46
in general payments reported to CMS, 2019-2025
12 companies · $2,043 in 2025
The $2,043 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $790 · 2021: $1,449 · 2022: $6,613 · 2023: $1,867 · 2024: $992 · 2025: $2,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,667 · Food and Beverage: $1,752 · Education: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,666.55 |
| Food and Beverage | $1,752.32 |
| Education | $482.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,657.86 | 2022-2025 | |
| Stryker Corporation | $3,114.56 | 2019-2025 | Infinity, Ortholoc 3di, Augment Injectable |
| Foundation Medical, LLC | $2,839.85 | 2022-2025 | |
| Medwest Associates | $1,200.00 | 2021 | |
| Paragon 28, INC. | $1,091.94 | 2019-2024 | Additive Orthopedics, Apex 3d, Precision Mis Bunion |
| Medical Device Business Services, INC. | $684.80 | 2019-2020 | |
| Orthofix Medical, INC. | $197.02 | 2021-2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $148.61 | 2020 | |
| Smith+Nephew, INC. | $145.33 | 2022 | |
| Depuy Synthes Sales INC. | $119.47 | 2020 | |
| Gemini Medical LLC | $119.04 | 2022 | |
| Axogen | $107.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sleasman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.